Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity Under Strategic Partnership With Pfizer
June 13, 2024
June 13, 2024
CAMBRIDGE, Massachusetts, June 13 -- Flagship Pioneering, a bioplatform innovation company, issued the following news release on June 12, 2024:
Flagship Pioneering and ProFound(TM) Therapeutics, a Flagship-founded company pioneering the expanded human proteome to develop novel medicines for a multitude of diseases, today announced a collaboration to conduct foundational research to identify potential next-generation first-in-class therapies for the treatment of obesity. The collabor . . .
Flagship Pioneering and ProFound(TM) Therapeutics, a Flagship-founded company pioneering the expanded human proteome to develop novel medicines for a multitude of diseases, today announced a collaboration to conduct foundational research to identify potential next-generation first-in-class therapies for the treatment of obesity. The collabor . . .